Literature DB >> 28123557

Comparative proteomic analysis of paclitaxel resistance-related proteins in human breast cancer cell lines.

Hiroya Fujioka1, Akiko Sakai2, Satoru Tanaka1, Kosei Kimura1, Akiko Miyamoto1, Mitsuhiko Iwamoto1, Kazuhisa Uchiyama1.   

Abstract

Paclitaxel is widely used to treat various cancers; however, resistance to this drug is a major obstacle to breast cancer chemotherapy. To identify the proteins involved in paclitaxel resistance, the present study compared the proteomes of MCF-7 human breast cancer cells and its paclitaxel-resistant subclone MCF-7/PTX. Using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time of flight mass spectrometry, 11 upregulated and 12 downregulated proteins were identified in MCF-7/PTX cells compared with the parental cell line. These 23 proteins were functionally classified as stress-induced chaperones, metabolic enzymes and cytoskeletal proteins. The anti-apoptotic proteins, stress-70 protein, 78-kD glucose-regulated protein, peptidyl-prolyl cis-trans isomerase A (PPIA) and heterogeneous nuclear ribonucleoprotein H3, were also upregulated in MCF-7/PTX cells. Notably, knockdown of the stress-response chaperone PPIA using small interfering RNA in MCF-7/PTX cells restored their sensitivity to paclitaxel. These findings indicated that PPIA may have an important role in paclitaxel resistance in MCF-7/PTX cells.

Entities:  

Keywords:  breast cancer; paclitaxel resistance; peptidyl-prolyl cis-trans isomerase A; proteome; proteomics

Year:  2016        PMID: 28123557      PMCID: PMC5245125          DOI: 10.3892/ol.2016.5455

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  35 in total

1.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  2D electrophoresis-based expression proteomics: a microbiologist's perspective.

Authors:  Isabel Sá-Correia; Miguel C Teixeira
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

Review 3.  Molecular mechanisms of erbB2-mediated breast cancer chemoresistance.

Authors:  Ming Tan; Dihua Yu
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 4.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

5.  Mass-spectrometry-based draft of the human proteome.

Authors:  Mathias Wilhelm; Judith Schlegl; Hannes Hahne; Amin Moghaddas Gholami; Marcus Lieberenz; Mikhail M Savitski; Emanuel Ziegler; Lars Butzmann; Siegfried Gessulat; Harald Marx; Toby Mathieson; Simone Lemeer; Karsten Schnatbaum; Ulf Reimer; Holger Wenschuh; Martin Mollenhauer; Julia Slotta-Huspenina; Joos-Hendrik Boese; Marcus Bantscheff; Anja Gerstmair; Franz Faerber; Bernhard Kuster
Journal:  Nature       Date:  2014-05-29       Impact factor: 49.962

6.  Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells.

Authors:  J Liao; N O Ku; M B Omary
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

Review 7.  Class III beta-tubulin in human development and cancer.

Authors:  Christos D Katsetos; Mary M Herman; Sverre J Mörk
Journal:  Cell Motil Cytoskeleton       Date:  2003-06

Review 8.  The HSP70 family and cancer.

Authors:  Maureen E Murphy
Journal:  Carcinogenesis       Date:  2013-04-04       Impact factor: 4.944

9.  Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Authors:  Xin Yi; John M Luk; Nikki P Lee; Jirun Peng; Xisheng Leng; Xin-Yuan Guan; George K Lau; Laura Beretta; Sheung-Tat Fan
Journal:  Mol Cell Proteomics       Date:  2007-10-14       Impact factor: 5.911

10.  Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.

Authors:  Henrica M J Werner; Jone Trovik; Mari K Halle; Elisabeth Wik; Lars A Akslen; Even Birkeland; Therese Bredholt; Ingvild L Tangen; Camilla Krakstad; Helga B Salvesen
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more
  7 in total

1.  Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis.

Authors:  Yi Seok Chang; Swati P Jalgaonkar; Justin D Middleton; Tsonwin Hai
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-07       Impact factor: 11.205

2.  G protein-coupled receptor kinase 5 modifies cancer cell resistance to paclitaxel.

Authors:  Joann Lagman; Paula Sayegh; Christina S Lee; Sarah M Sulon; Alec Z Jacinto; Vanessa Sok; Natalie Peng; Deniz Alp; Jeffrey L Benovic; Christopher H So
Journal:  Mol Cell Biochem       Date:  2019-07-30       Impact factor: 3.842

3.  Hydrous icaritin nanorods with excellent stability improves the in vitro and in vivo activity against breast cancer.

Authors:  Yian Wang; Tiantian Huang; Haowen Li; Jingxin Fu; Hui Ao; Likang Lu; Meihua Han; Yifei Guo; Feng Yue; Xiangtao Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer.

Authors:  Hui Ao; Yijing Li; Haowen Li; Yian Wang; Meihua Han; Yifei Guo; Rongxing Shi; Feng Yue; Xiangtao Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

5.  Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases.

Authors:  Nina Zila; Andrea Bileck; Besnik Muqaku; Lukas Janker; Ossia M Eichhoff; Phil F Cheng; Reinhard Dummer; Mitchell P Levesque; Christopher Gerner; Verena Paulitschke
Journal:  Clin Proteomics       Date:  2018-03-09       Impact factor: 3.988

6.  Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3.

Authors:  Junjun Chen; Xiangqi Zhang; Xiao Xiao; Yawei Ding; Wei Zhang; Meizhi Shi; Jiao Yang; Ying Liu; Yonglong Han
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

7.  Carbonic anhydrase 12 gene silencing reverses the sensitivity of paclitaxel in drug-resistant breast cancer cells.

Authors:  Ting Huang; Lijuan Tang; Huan Wang; Lu Lin; Jing Fu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.